magnesium(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×5“Magnesium sulphate use was associated with lower ICU 30-day all-cause mortality rates (HR, 0.75; 95% CI, 0.62–0.90; P = 0.002) (Table 2).”
Quoted verbatim from Association of magnesium sulphate use with mortality in patients with acute respiratory distress syndrome: a retrospective propensity score-matched cohort study.. - Study
- cohort
- Duration
- 4 weeks
- Dose
- intravenous magnesium sulphate during ICU stay; total dose mainly 1-10 g
- Population
- Adult ICU patients with ARDS in the MIMIC-IV database, propensity-score-matched cohort of magnesium sulphate users against non-users; horizon is ICU 30-day
Effect 0.75 hazard ratio, 95% CI 0.62 to 0.9
Association of magnesium sulphate use with mortality in patients with acute respiratory distress syndrome: a retrospective propensity score-matched cohort study.2025PMID:41073637Permalink
Keep reading
- Everything the graph holds on magnesium(2+)
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5K818RNK24EFEDMH6D342HC